Allergy Therapeutics plc (AIM:AGY)
London
· Delayed Price · Currency is GBP · Price in GBX 10.70
+0.20 (1.90%)
At close: Dec 5, 2025
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 657.13 million as of December 5, 2025. Its market cap has increased by 175.73% in one year.
Market Cap
657.13M
Enterprise Value
679.98M
Revenue
55.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.70
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 657.13M, an increase of 2,049.64%. That is a compound annual growth rate of 15.60%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |